Chad vs Saint Vincent and the Grenadines: HIV-positive TB patients on ART (antiretroviral therapy)
Chad
100.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2023
Chad rank
1st
Saint Vincent and the Grenadines rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Chad
- Saint Vincent and the Grenadines
How they compare
Chad currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
Across all 8 years both countries report, Saint Vincent and the Grenadines has been ahead every year.
Chad ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chad | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.8% | 86.8% | 41.0% | Saint Vincent and the Grenadines |
| 2020s | 99.2% | 100.0% | 0.8% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Chad or Saint Vincent and the Grenadines?
- Chad, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Chad and Saint Vincent and the Grenadines?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Saint Vincent and the Grenadines?
- 8 years are reported by both, from 2010 to 2023.
- How do Chad and Saint Vincent and the Grenadines rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Chad ranks 1st and Saint Vincent and the Grenadines ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.